Pilot Study of Swift Microwave Device for Onychomycosis

Status Recruiting

Clinical Trial Summary

This is an open, single site, pilot study in Canadian subjects diagnosed with mild to moderate toenail onychomycosis caused by dermatophytes. Three microwave treatment frequencies will be compared for efficacy and safety, evaluated by frequency of treatment-related adverse events, clinical improvement of a treated target toenail and inactivation/elimination of fungus in the target toenail. Outcomes will be evaluated at Month 6, Month 9 and Month 12 after initiation of treatments. Subjects not achieving 'temporary increase in clear nail' at Month 6 may receive extra microwave treatments to Month 9 or Month 12 to improve outcomes.

Clinical Trial Description

This is an open, single site, pilot study in Canadian subjects diagnosed with mild to moderate toenail onychomycosis caused by dermatophytes. A total of 45 subjects will be enrolled in the study. All eligible subjects who provide written informed consent will be randomized to one of three groups (15 subjects in each group): Group A, B or C. The treatment regimen for each group is as follows: Group A: Subjects will receive treatment on Day 0 and then weekly in the first month followed by monthly treatment for a further 4 months (9 treatments). Group B: Subjects will receive treatment on Day 0 and then every two weeks in the first month followed by monthly treatment for a further 4months (7 treatments). Group C: Subjects will receive treatment on Day 0 and then once every two weeks in the first six months (12 treatments). For all groups, patients not achieving 'FDA efficacy' levels at Month 6 End Visit and/or Month 9 End Visit will be offered continuation of treatments once monthly for 3 months to determine if additional treatment will continue to be safe and increase efficacy. Patients may refuse additional treatment, while continuing in safety follow-up to Months 9/12. Subjects will be followed up every 3 months for safety and efficacy to Month 12, and at any treatment intervals occurring between these main visits. Efficacy will be assessed by changes in affected nail area and length, both in clinic and through photos. Mycology sampling will be performed at pre-determined intervals to assess fungal presence and viability post-treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05674747
Study type	Interventional
Source	Mediprobe Research Inc.
Contact	Aditya Gupta, MD,PhD
Phone	519-851-9715
Email	agupta@mediproberesearch.com
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	March 27, 2023
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03110029` - Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish	Phase 4
Active, not recruiting	`NCT05110638` - Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis	Phase 1
Completed	`NCT05260450` - Laser Treatment of Toenail Onychomycosis With a 1064 nm Nd:YAG-laser	N/A
Completed	`NCT03382717` - Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis	N/A
Withdrawn	`NCT03094468` - Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis	Phase 3
Recruiting	`NCT06006455` - Effect of the Erchonia® LunulaLaser™ for the Treatment of Toenail Onychomycosis	N/A
Not yet recruiting	`NCT03098342` - Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment	N/A
Completed	`NCT03216200` - Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)	N/A
Recruiting	`NCT04042857` - Safety and Efficacy of Next Science Gel on Toenail Fungus	N/A
Active, not recruiting	`NCT05135910` - To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis	Phase 2
Active, not recruiting	`NCT05139888` - Light Therapy for Onychomycosis Study	N/A
Completed	`NCT04961684` - Clinical Evaluation of Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis	N/A
Completed	`NCT03141840` - Clinical Trial of Topical ABL01 Treatment of Onychomycosis	N/A
Recruiting	`NCT04084782` - An Internet Mediated Research Study to Assess the Quality of Life of Consumers With Self-reported Fungal Nail Infection (Onychomycosis) During Treatment With Scholl Fungal Nail.
Withdrawn	`NCT03066336` - A Study to See if Low Level Laser Light Can Help to Treat Toenail Fungus	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.